EDSA news

Latest 2 stories · newest Jun 11, 2026

EDSA

Edesa Biotech prices securities offering of common shares and pre-funded warrants

Edesa Biotech executed a securities purchase agreement dated June 10, 2026, to sell common shares and pre-funded warrants to accredited investors under Regulation D exemption. The offering provides capital funding and includes registration rights for the purchased securities under federal and state …

Offering Jun 11, 2026 sentiment +0.50 SEC filing ↗

EDSA

Edesa Biotech increases equity plan shares by 750,000 and removes option grant limits

Edesa Biotech's board approved Amendment No. 5 to its 2019 Equity Incentive Compensation Plan, effective March 18, 2026, increasing reserved shares by 750,000 and eliminating annual option grant limits per participant. The amendments require shareholder approval at the 2026 Annual General Meeting an…

Other May 29, 2026 sentiment +0.10 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same EDSA feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/EDSA/newsSTART FREE